Register
|
Login
The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
NEWS
CONFERENCES
VIDEOS
Case-Based Peer Perspectives
Expert Perspective Virtual Tumor Board
Interviews
Investigator Perspectives
Precision Medicine
PUBLICATIONS
Evolving Paradigms
Targeted Therapies in Oncology
The Journal of Targeted Therapies in Cancer
ONCAlert | Upfront Therapy for mRCC
Specialties >>
AML
Biosimilars
Bladder Cancer
Brain Cancer
Breast Cancer
CLL
Colorectal Cancer
DLBCL
EGFR+ Lung Cancer
Follicular Lymphoma
Gastric Cancer
Genitourinary Cancers
GI Cancers
Gynecologic Cancers
HCC
Head & Neck Cancers
Hematology
HER2-Negative Breast Cancer
Immunotherapy
Lung Cancer
Lymphomas
Mantle Cell Lymphoma
Melanoma
MPNs
Multiple Myeloma
Ovarian Cancer
Prostate Cancer
Renal Cell Carcinoma
Sarcoma
Skin Cancers
Thyroid Cancers
Partners >>
Dialogues in Diagnostics
Differential Diagnosis
Case-Based Peer Perspectives
Email Sign-Up
Latest News
MORE >>
Expert Discusses Ongoing HCC, NETs Research
February 22, 2019
Daneng Li, MD, sheds light on some of the currently available regimens and ongoing research efforts being conducted in HCC and NETs.
Read more >>
Feature:
Pembrolizumab Approved by FDA for Stage III Melanoma
Learn More >>
Adding Ibrutinib to CAR T-Cell Therapy Increases Response Rates in CLL
February 22, 2019
Mesa Discusses Evolving Role of Interferon in MPN Treatment Paradigm
February 22, 2019
Low-Dose R-CHOP Yields Similar Survival Benefits Compared With Standard Dose in Elderly Patients With DLBCL
February 21, 2019
Expert Reviews CDK4/6 Inhibitor Data in HR+/HER2- Breast Cancer
February 21, 2019
Videos
Updated Findings With Ruxolitinib in Polycythemia Vera
Examining the Use of CDK4/6 Inhibitors in HER2-Negative Breast Cancer
Next Steps for CAR T Cells in B-Cell Lymphomas
Managing Immunotherapy Toxicities in Melanoma
Case Studies
Case: Relapsed/Refractory Waldenstrom Macroglobulinemia
Elucidating a Case of Locally Advanced CSCC
Prognosis for Stage IV Hodgkin's Lymphoma & Patient Expectations
Managing Extranodal MZL
Latest Journal
All Journals >>
Targeted Therapies in Oncology
February 2 2019
Technology Continues to Grow Despite Payment Hurdles, According to ACCC Survey
Advances in Breast Cancer and Hematology Increasingly Rely on Immunotherapy
Updates in Chronic Lymphocytic Leukemia: 60th ASH Annual Meeting
MORE >>
Most Popular
Expert Reviews CDK4/6 Inhibitor Data in HR+/HER2- Breast Cancer
Pembrolizumab Falls Short in Confirmatory HCC Trial
Mesa Discusses Evolving Role of Interferon in MPN Treatment Paradigm
Encouraging PFS Data Seen With Maintenance Ixazomib in Multiple Myeloma
